Feb 10, 2026 | Benefits Advisory Conference, Benefits management, Cancer, Caroline Fraker, Compliance, Forensic claims review, Gene therapy, GLP-1s, High-cost claims, MedBen University, No Surprises Act (NSA), Obesity, Orphan diseases, Pharmacy, Specialty Drugs, Stop-Loss, Transplants
Consultants and advisors from 10 different states attended the MedBen 2026 Benefits Advisory Conference on January 28. The event featured insights from some of the industry’s most respected voices and gave brokers a clearer view of today’s benefits landscape, what...
Mar 18, 2024 | DNA, Drug costs, Drugmakers, Gene therapy, Health care costs, Rx Costs, Spending
Back in late 2022, MedBen spotlighted the growth of gene therapy, a transformative medical approach that potentially cures genetic disorders by correcting or replacing an individual’s DNA. As we noted, these therapies go beyond treatment to literally...
Feb 6, 2024 | Claims, Claims data, Cost Savings, Drug costs, Gene therapy, Genetic testing, MedBen News, MedBen Rx, MedBen University, Pharmacogenics, Pharmacy Benefits Manager (PBM), Self-funding, Specialty Drugs, Stop-Loss
MedBen recently had the honor to welcome some of the most respected names in the benefits management industry. At the invitation-only 2024 Benefits Advisory Conference on January 26, attending brokers learned about health plan innovations that will help self-funded...
Feb 3, 2023 | Alternative Reimbursement Strategies, Claims, Cost Savings, Direct-to-Employer Contracting, Drug costs, Forensic claims review, Gene therapy, Health care costs, Inflation, MedBen Rx, MedBen WellLiving, Prescription, Rx Costs, Savings, Specialty Drugs, Wellness
Even though health care costs have not seen the same rate of inflation as other industries, that’s about to change. Fortunately, MedBen has a variety of inflation-hedging solutions to counter rising costs. As a recent Self-Insurer article notes, health care...
Jan 23, 2023 | Avande, Cost Savings, Drug costs, Gene therapy, Luke Burchard, MedBen Rx, Rx Costs, Savings
In two recent articles, we touched on the growing prevalence of high-cost drugs, some with price tags in the thousands and even millions of dollars: Drugmakers are raising prices on over 350 unique drugs this month.Innovative gene therapies have emerged that cost as...
Dec 12, 2022 | Drug costs, Gene therapy, MedBen Rx, Prescription
The Self-Insurer magazine recently examined the emergence of innovative gene therapies that carry substantial benefits… and hefty price tags. The FDA just approved a hemophilia B gene therapy that costs $3.5 million a dose, making it the world’s most...
